Mir-21 Promotes Cardiac Fibrosis After Myocardial Infarction Via Targeting Smad7
Author(s) -
Jinxia Yuan,
Hongtao Chen,
Dawei Ge,
Yu Xu,
Haihua Xu,
Yang Yang,
Ming Gu,
Yuhe Zhou,
Jingdong Zhu,
Ting Ge,
Qun Chen,
Yue Gao,
Yanqing Wang,
Xiaowei Li,
Y Zhao
Publication year - 2017
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000479995
Subject(s) - in vivo , myocardial infarction , fibrosis , cardiac fibrosis , western blot , medicine , myocardial fibrosis , luciferase , reporter gene , microrna , cardiac function curve , transforming growth factor , cancer research , gene expression , cardiology , biology , heart failure , cell culture , transfection , gene , biochemistry , genetics , microbiology and biotechnology
Cardiac fibrosis after myocardial infarction (MI) has been identified as an important factor in the deterioration of heart function. Previous studies have demonstrated that miR-21 plays an important role in various pathophysiological processes in the heart. However, the role of miR-21 in fibrosis regulation after MI remains unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom